Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Baicalin may help treat severe drug-induced skin reactions.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

The compound 4c showed strong potential as an anticancer agent.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Tofacitinib might be used to treat hair loss.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.